Islet Management’s Alignment Healthcare ALHC Stock Holding History

Islet Management’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-225,000	Closed	-$3.16M	–	125
2021 Q4	$3.16M	Buy	+225,000	New	+$3.94M	0.09%	157

Other funds holding ALHC

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Islet Management's ALHC Position: Q1 2022 in Review

Islet Management sold out of Alignment Healthcare (ALHC) in Q1 2022, closing a stake of 225,000 shares — an estimated $3.16M sold.

Islet Management first reported a position in ALHC in Q4 2021 and held it in 1 quarter. The position peaked at $3.16M in Q4 2021. 90 funds tracked by Wall St. Rank hold ALHC as of Q1 2022.

Islet Management reported no remaining Alignment Healthcare position as of Q1 2022 after selling out during the quarter.
Islet Management sold 225,000 Alignment Healthcare shares in Q1 2022, an estimated $3.16M.
Islet Management first reported a position in Alignment Healthcare in Q4 2021 and held it in 1 quarter.
Islet Management's Alignment Healthcare position peaked at $3.16M in Q4 2021.
90 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2022.

Based on Islet Management's 13F filing for Q1 2022, filed 13 May 2022.